Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study
- 24 December 2009
- journal article
- Published by Springer Science and Business Media LLC in Hepatology International
- Vol. 4 (1), 396-405
- https://doi.org/10.1007/s12072-009-9157-7
Abstract
967 patients with unresectable and untransplantable, biopsy-proven hepatocellular carcinoma (HCC) were prospectively evaluated at baseline and followed up till death. Survival was the end point. We found that male gender, ascites, cirrhosis, portal vein thrombosis (PVT), elevated AFP or bilirubin, or alkaline phosphatase, were each statistically significant adverse prognostic factors. Patients with normal AFP survived longer than those with elevated AFP, even in the presence of PVT, large or bilobar tumors or cirrhosis. We used a bivariate analysis to separate patient sub groups based on liver function and tumor characteristics and found clear discrimination in survival between subsets; in addition both cirrhosis and presence of PVT were significant factors. We also used a purely mathematical approach to derive subgroups and a prognostic model for individual patients. Interestingly, the two approaches gave similar predictive information, which opens the possibility of a more detailed mathematical analysis in the future. The results of this large dataset show that amongst non-surgical HCC patients, there are clear subsets with longer survival. The data supports the concept of heterogeneity of HCC. The three factors, bilirubin, AFP, and PVT predominate in prognosis.Keywords
This publication has 47 references indexed in Scilit:
- Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosisHepatology, 2007
- Comparison of staging systems to predict survival in hepatocellular carcinomaLiver International, 2006
- Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotypeJCI Insight, 2006
- Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems.Journal of Internal Medicine, 2004
- The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinomaLiver Transplantation, 2004
- Comprehensive Proteomic Profiling Identifies Serum Proteomic Signatures for Detection of Hepatocellular Carcinoma and Its SubtypesClinical Chemistry, 2003
- Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in TorontoGut, 2002
- A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolizationCancer, 2000
- A new prognostic classification for predicting survival in patients with hepatocellular carcinomaJournal of Hepatology, 1999
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999